Gilead Sciences, Inc.GILDNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank86
3Y CAGR+5.7%
5Y CAGR+4.9%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+5.7%/yr
vs +5.8%/yr prior
5Y CAGR
+4.9%/yr
Consistent
Acceleration
-0.1pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $25.52B | +13.4% |
| 2024 | $22.50B | +9.1% |
| 2023 | $20.62B | -4.7% |
| 2022 | $21.62B | +4.4% |
| 2021 | $20.70B | +2.9% |
| 2020 | $20.12B | +13.2% |
| 2019 | $17.77B | +2.9% |
| 2018 | $17.27B | -20.5% |
| 2017 | $21.74B | -16.8% |
| 2016 | $26.13B | - |